Since most adults have some degree of cardiometabolic risk, the CIT has been designed to evaluate and monitor the extent of this risk for patients.
Cardiovascular disease, type 2 diabetes, metabolic syndrome, and obesity are widespread and very common among patients. These lifestyle diseases are largely preventable, treatable, and reversible. The right combination of blood tests can unmask and monitor risk for serious health problems including premature death and dramatically reduce quality of life.
In this webinar Dr David Wright discuss the markers and their interpretation on the new KBMO Cardiovascular Inflammation Test (CIT)
